Skip to Main Content

Paper Details

Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study.
Lancet Infect Dis
80
2022
Author NameAffiliation
Jason R AndrewsStanford University
Otavio T RanzaniBarcelona Institute for Global Health, Heart Institute, Hospital das Clinicas, Faculdade de Medicina
Margaret L LindYale School of Public Health
Derek A T CummingsUniversity of Florida, USA Emerging Pathogens Institute
Natalie E DeanRollins School of Public Health, Emory University
Albert I KoInstituto Goncalo Moniz, Yale School of Public Health
Julio CrodaYale School of Public Health, USA Universidade Federal de Mato Grosso do Sul
Manoel Barral-NettoInstituto Goncalo Moniz, Brazil Center for Data and Knowledge Integration for Health, Brazil Faculdade de Medicina, Universidade Federal da Bahia
  • 1 - 8

Datasets